EUVIMEDEUVIMED entdecken
Crossref

Eliciting Patient-Centric Value Parameters: A National Best-Worst Scaling Profile Case Survey for Second-Line Antidiabetic Drugs in China

Dai Lian iD, Jing Liu, Yan Wei, Yi Yang, Yanfeng Ren, Shiyi Bao, Liu Liu, Shimeng Liu iD, Yingyao Chen iD

The Patient - Patient-Centered Outcomes Research · 2026

DOI: 10.1007/s40271-025-00776-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Patient - Patient-Centered Outcomes Research, 2026. Verfasst von Dai Lian und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Fudan University, 138 Yi Xue Yuan Rd, Shanghai, 200032, People's Republic of China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Patient Preference. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: China faces the world's largest diabetes burden, with a 12.4% prevalence. A wide range of second-line therapies is available for patients with type 2 diabetes mellitus (T2DM), each with distinct characteristics. Although current guidelines advocate for a patient-centered approach in selecting second-line treatments, empirical evidence on Chinese patient's preferences for these therapies remains limited. We therefore elicited population‑level preferences using a Best-Worst Scaling profile‑case (BWS‑2) survey to inform decision making. METHOD: A seven-attribute instrument was designed through literature review, expert input, and a BWS object-case study used for attribute refinement (reported elsewhere). The final study employed BWS‑2 to elicit preferences across benefit, risk, and cost attributes. An orthogonal main‑effects design generated the choice sets. The survey was conducted through in-person interviews with patients with T2DM at healthcare institutions in three Chinese regions (eastern, central, and western). Data were analyzed using counting approach, conditional, and mixed logit regression. Preference heterogeneity was explored with subgroup analyses and latent class analysis (LCA). RESULTS: Among 1517 respondents, counting approach and logit estimates were consistent; most attribute coefficients were statistically significant in logit analysis, with patients showing the highest preference for reduction in HbA1c, cardiovascular protection, and zero out-of-pocket costs compared with the reference levels. Weight change and mode of administration exerted modest influence. LCA identified six unobserved subgroups. Preferences heterogeneity were also explored by splitting the sample according to patient urban-rural residence and income characteristics. CONCLUSIONS: Chinese patients with T2DM prioritized HbA1c reduction, cardiovascular benefits, and cost, while weight change was rated as the least important attribute. LCA further revealed preference heterogeneity, including limited concern for adverse events and neutral attitudes toward all attributes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hypoglycemic AgentsPatient PreferenceHumansChinaFemaleMaleMiddle AgedAgedPatient-Centered CareAdultSurveys and Questionnaires

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • School of Public Health, Fudan University, 138 Yi Xue Yuan Rd, Shanghai, 200032, People's Republic of China.
  • National Health Commission Key Laboratory of Health Technology Assessment (Fudan University), Shanghai, China.
  • School of Management, Hainan Medical University, Haikou, China.
  • Jincheng Center for Disease Control and Prevention, Jincheng, China.
  • Department of Teaching Management, Nanjing Medical University, Nanjing, China.
  • School of Public Health, Fudan University, 138 Yi Xue Yuan Rd, Shanghai, 200032, People's Republic of China. smliu@fudan.edu.cn.

ORCID-Profile: Dai Lian, Shimeng Liu, Yingyao Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lian, D., Liu, J., Wei, Y., Yang, Y., Ren, Y., Bao, S., Liu, L., Liu, S., & Chen, Y. (2026). Eliciting Patient-Centric Value Parameters: A National Best-Worst Scaling Profile Case Survey for Second-Line Antidiabetic Drugs in China. The Patient - Patient-Centered Outcomes Research. https://doi.org/10.1007/s40271-025-00776-0

Vancouver

Lian D, Liu J, Wei Y, Yang Y, Ren Y, Bao S, et al. Eliciting Patient-Centric Value Parameters: A National Best-Worst Scaling Profile Case Survey for Second-Line Antidiabetic Drugs in China. The Patient - Patient-Centered Outcomes Research. 2026. doi:10.1007/s40271-025-00776-0

BibTeX
@article{Lian2026,
  author = {Lian, Dai and Liu, Jing and Wei, Yan and Yang, Yi and Ren, Yanfeng and Bao, Shiyi and Liu, Liu and Liu, Shimeng and Chen, Yingyao},
  title = {Eliciting Patient-Centric Value Parameters: A National Best-Worst Scaling Profile Case Survey for Second-Line Antidiabetic Drugs in China},
  journal = {The Patient - Patient-Centered Outcomes Research},
  year = {2026},
  doi = {10.1007/s40271-025-00776-0}
}
Kostenlos starten →